IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis.
Lichao YaoXue HuMengqin YuanQiuling ZhangPingji LiuLian YangKai DaiYing-An JiangPublished in: Journal of clinical and translational hepatology (2023)
Our study provides a theoretical basis for the future use of BMDM-based cell therapy to treat liver cirrhosis.